News
ENTX
3.305
+0.76%
0.025
Weekly Report: what happened at ENTX last week (1109-1113)?
Weekly Report · 5d ago
Weekly Report: what happened at ENTX last week (1102-1106)?
Weekly Report · 11/09 09:07
Entera Bio Q3 Loss Widens; Expects Phase 3 Osteoporosis Topline Data In H2'28
NASDAQ · 11/09 09:05
Entera Bio Ltd. Reports Third Quarter 2026 Financial Results and $265.9 million Cash Balance
NASDAQ · 11/06 23:33
Entera Bio Reports Third-Quarter Results, Advances Osteoporosis Programs
TipRanks · 11/06 21:55
Entera Bio GAAP EPS of -$0.11 misses by $0.04
Seeking Alpha · 11/06 21:23
Entera Bio Q3 EPS $(0.11) Misses $(0.07) Estimate
Benzinga · 11/06 21:17
Weekly Report: what happened at ENTX last week (1026-1030)?
Weekly Report · 11/02 09:07
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/30 12:05
Why Civeo Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/30 09:03
Entera Bio Ltd. Appoints Dr. Juan Camilo Arjona Ferreira to Board of Directors
NASDAQ · 10/27 15:20
Entera Bio adds director to strengthen women’s health
TipRanks · 10/27 12:30
Weekly Report: what happened at ENTX last week (1019-1023)?
Weekly Report · 10/26 09:07
Weekly Report: what happened at ENTX last week (1012-1016)?
Weekly Report · 10/19 09:07
Entera Bio Presents Phase 2 Data Supporting EB613 Benefits In Women With Osteoporosis At ASBMR 2026 Annual Meeting
Benzinga · 10/13 11:02
Weekly Report: what happened at ENTX last week (1005-1009)?
Weekly Report · 10/12 09:08
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/09 12:05
Alignment Healthcare, RenX Enterprises And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Benzinga · 10/09 12:01
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
TipRanks · 10/07 14:00
Entera Bio Strengthens Board with Veteran Biopharma Leader
TipRanks · 10/06 12:36
More
Webull provides a variety of real-time ENTX stock news. You can receive the latest news about Entera Bio Ltd through multiple platforms. This information may help you make smarter investment decisions.
About ENTX
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.